News

Regeneron Pharmaceuticals, Inc.  and CytomX Therapeutics, Inc.  announced a collaboration and licensing agreement to create conditionally-activated investigational bispecific cancer therapies utilizing CytomX's Probody® therapeutic platform and Regeneron's Veloci-Bi® bispecific antibody development platform. The collaboration is strategically focused on applying CytomX's...

UPS announced that it has closed on the acquisition of Bomi Group, an industry-leading multi-national healthcare logistics provider. Through the acquisition, the company's healthcare unit, UPS Healthcare, will add temperature-controlled facilities in 14 countries, and 3,000 highly-skilled employees to...

More than 143 million COVID-19 doses had been given in the UK as of the end of May 2022 since the start of this historic immunisation programme in 2020. Without a doubt, the pandemic vaccination programme has significantly contributed...

Researchers have made a ground-breaking revelation: the parasites that cause leprosy can rewire cells to enlarge the liver. According to the most recent study, it may be possible to adapt this natural mechanism from the leprosy disease to rejuvenate ageing...

Researchers from Australia's Centenary Institute and the University of Sydney have created a novel nasal vaccination system that promotes strong lung resistance and tolerance against the SARS-CoV-2 coronavirus. The newly developed vaccine strategy, which was successfully tested in mice and...

Through its approach to NHS England, the non-profit organisation Kidney Cancer UK was able to gain funding for the National Institute for Health and Care Excellence (NICE) to create the first-ever clinical guidelines for the disease. The organisation conducted an...

Under new regulations that would oversee a pandemic agreement approved by the World Health Organization, which Reuters has reviewed, pharmaceutical companies might be required to disclose prices and agreements for any medications they produce to battle future global health...